-+ 0.00%
-+ 0.00%
-+ 0.00%

Simulations Plus Partners With Nvidia Over GPU-Accelerated Simulation, AI-Assisted Workflows For Computationally Intensive Modeling Applications Within The Drug Development Lifecycle

Benzinga·05/06/2026 11:56:46
Listen to the news

Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the launch of a technical collaboration with NVIDIA focused on enabling GPU-accelerated simulation and AI-assisted workflows for computationally intensive modeling applications within the drug development lifecycle.